049180 — Cellumed Co Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- KR₩84bn
- KR₩90bn
- KR₩140bn
Annual cashflow statement for Cellumed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 8,430 | -5,387 | -37,945 | -31,817 | -2,184 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -7,123 | 3,796 | 28,769 | 28,313 | -768 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -13,547 | -8,819 | 1,266 | 1,907 | -1,575 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10,788 | -8,488 | -5,395 | -419 | -3,860 |
| Capital Expenditures | -2,272 | -5,755 | -7,295 | -1,784 | -286 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -16,646 | 1,182 | -271 | -2,594 | -6,612 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -18,917 | -4,573 | -7,567 | -4,378 | -6,898 |
| Financing Cash Flow Items | 51 | 62.4 | -37.2 | -18.4 | 3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31,158 | 2,212 | 9,192 | 8,168 | 8,182 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,452 | -10,683 | -3,774 | 3,387 | -2,574 |